Drugs / buprenorphine/naloxone
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT03266445 Comparator | Oct 2018 → Dec 2021 | opiate dependence | Massachusetts General Hospital | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | buprenorphine/naloxone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03266445 ↗ |